Nasdaq Aura News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aura Biosciences (NASDAQ:AURA – Get Free Report) and Caribou Biosciences (NASDAQ:CRBU – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, risk, dividends, institutional ownership and profitability. Institutional and Insider Ownership 96.8% of Aura […]

Levin Capital Strategies L.P. grew its position in shares of Aura Biosciences, Inc. (NASDAQ:AURA – Free Report) by 15.9% during the third quarter, according to its most recent filing with the SEC. The firm owned 81,095 shares of the company’s stock after acquiring an additional 11,095 shares during the period. Levin Capital Strategies L.P. owned […]

Aura Biosciences (NASDAQ:AURA – Free Report) had its price target reduced by BTIG Research from $38.00 to $21.00 in a research report released on Friday, Benzinga reports. BTIG Research currently has a buy rating on the stock. Separately, JMP Securities lowered their target price on shares of Aura Biosciences from $21.00 to $19.00 and set […]

Regency Capital Management Inc. DE reduced its position in shares of Aura Biosciences, Inc. (NASDAQ:AURA – Free Report) by 1.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 543,675 shares of the company’s stock after selling 10,611 shares during the period. […]

Aura Biosciences (NASDAQ:AURA – Get Rating) had its price target decreased by JMP Securities from $25.00 to $24.00 in a research report released on Friday, The Fly reports. Aura Biosciences Trading Up 0.4 % AURA stock opened at $10.25 on Friday. Aura Biosciences has a twelve month low of $8.13 and a twelve month high […]